The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

(2010) John S. Albin et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

No Evidence of an Association between theAPOBEC3BDeletion Polymorphism and Susceptibility to HIV Infection and AIDS in Japanese and Indian Populations

(2010) Sakiko Itaya et al.   JOURNAL OF INFECTIOUS DISEASES

APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms

(2010) J. L. Mbisa et al.   JOURNAL OF VIROLOGY

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction

(2010) Eric W. Refsland et al.   NUCLEIC ACIDS RESEARCH

APOBEC3 Proteins Inhibit LINE-1 Retrotransposition in the Absence of ORF1p Binding

(2009) Nika Lovšin et al.   Annals of the New York Academy of Sciences

APOBEC3BDeletion and Risk of HIV‐1 Acquisition

(2009) Ping An et al.   JOURNAL OF INFECTIOUS DISEASES

Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets

(2009) F. A. Koning et al.   JOURNAL OF VIROLOGY

HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain

(2009) Y. Iwatani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA

(2009) Rebecca A Russell et al.   Retrovirology

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA

(2009) Yeshitila N Friew et al.   Retrovirology

Multiple ways of targeting APOBEC3–virion infectivity factor interactions for anti-HIV-1 drug development

(2009) Jessica L. Smith et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1

(2009) Hendrik Huthoff et al.   PLoS Pathogens

Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance

(2009) Patric Jern et al.   PLoS Pathogens

The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements

(2008) Ya-Lin Chiu et al.   Annual Review of Immunology

Two Regions within the Amino-Terminal Half of APOBEC3G Cooperate To Determine Cytoplasmic Localization

(2008) M. D. Stenglein et al.   JOURNAL OF VIROLOGY

Interactions of Murine APOBEC3 and Human APOBEC3G with Murine Leukemia Viruses

(2008) S. J. Rulli et al.   JOURNAL OF VIROLOGY

Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins

(2008) R. S. LaRue et al.   JOURNAL OF VIROLOGY

HIV-1 Vif, APOBEC, and Intrinsic Immunity

(2008) Ritu Goila-Gaur et al.   Retrovirology